The Ledger

Every statement that passed quotation and attribution checks. Mix any filter with any other: certainty 1/5, debate potential 5/5, or both at once.

clear all ✕

why aren't all 9 resolved? a statement only gets an assessment when the public record can support or contradict it. opinions and what-ifs never can, and 0 checkable ones are still open, waiting for their date. predictions held up or didn't; assertions are supported or contradicted. on every card: ▮▮▮▮▮ certainty · ▮▮▮▮▮ debate potential. speakers are clickable

Prediction Not checkable as stated
Wickramasekara: AI in scientific discovery will focus on augmentation over autonomy next 1-2 years
“While I would love for that to happen, and I'm maybe more optimistic on a longer time scale, we will get there. I think in the short term, I'm next one to two years, which, you know, already feels like an eternity in AI time. I'm a little bit more bullish on s…”
Sajith Wickramasekara Nov 13, 2025 ▶ 19:03 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
Prediction Not checkable as stated
Wickramasekara: Pure AI biology model companies must morph into biopharma
“I think it's unlikely, it's possible, but it's unlikely that sort of, hey, they're just gonna remain pure model companies who just do deals with pharma, where pharma, you know, pays them a hundred million dollars upfront or something like that, and they have f…”
Sajith Wickramasekara Nov 13, 2025 ▶ 27:44 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
Insight
Benchling CEO: Software engineers with bio expertise effectively do not exist
“If I was only hiring like software people who knew bio, I would have like exhausted the pool 10 years ago. It just doesn't exist. We have to take the software people, take the science people, make them sit together.”
Sajith Wickramasekara Nov 13, 2025 ▶ 41:02 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
Prediction Not checkable as stated
Wickramasekara: AI will convert life sciences skeptics to structured data tools
“But now with like AI, one, I think the benefits are a much more immediately obvious to everyone. And so that's going to be this amazing tailwind to try to like do better here. And I think it will convince a lot of people who might have been skeptics in the pas…”
Sajith Wickramasekara Nov 13, 2025 ▶ 31:24 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
Opinion
Wickramasekara: Biology AI has powerful models but lacks a ChatGPT-like interface
“I think we're like, we've got GPT, but there's no chat. Like, that, that's kind of how I think about it. Like, I think the chat, and I mean chat metaphorically, like, that was the interface that made things really take off in, in software. And I don't think it…”
Sajith Wickramasekara Nov 13, 2025 ▶ 21:37 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
Insight
Wickramasekara: A co-founder's true power lies in moral authority
“I feel like the power of being a co-founder is actually just in moral authority”
Sajith Wickramasekara Nov 13, 2025 ▶ 35:28 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
Assertion Not checkable as stated
Wickramasekara: Benchling AI saved a customer an 8-month redundant mouse study
“We had a customer that was getting ready to run some mouse studies, and they were looking at 20 different mouse models, and they used a deep research our deep research capability to look at all the historical mouse studies that they had run, and it turned out …”
Sajith Wickramasekara Nov 13, 2025 ▶ 17:36 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
Disclosure
Wickramasekara: Benchling released a deep research AI agent over lab data
“And so we've released this deep research agent. It works similar to the deep research agents from Anthropic and other foundation labs. But what it does is it works over Benchling data with the context of the Benchling data model.”
Sajith Wickramasekara Nov 13, 2025 ▶ 17:07 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
Assertion Not checkable as stated
Benchling serves 1,300 biopharma companies and 7,000 academic institutions
“Today we work with about 1300 biotech and pharma companies scientists at over 7000 academic institutions, universities, all, all around the world. And our software powers, you know, household names like Moderna and Sanofi and Eli Lilly and Regeneron, but also …”
Sajith Wickramasekara Nov 13, 2025 ▶ 1:37 No Priors Ep. 140 | With Benchling Co-Founder and CEO Sajith Wickramasekara
Made with StarZero

Turn any episode into a week of clips.

This entire site, over 100 episodes transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.